Estrogen therapy may improve schizophrenia symptoms in women, highlighting its potential role as an adjunctive treatment.

A recent study reveals the limitations of ADHD screening tools, highlighting the risks of overdiagnosis in adults based on self-reports.

Research explores the kidney injury risks associated with lithium compared to valproate, revealing unexpected findings.

Esketamine outperforms quetiapine in TRD remission rates, but the clinical significance of this difference remains uncertain.

Harish Kavirajan revisits the use of antipsychotics in depression, weighing small benefits against serious risks, like tardive dyskinesia and metabolic issues.